Cargando…

FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP

Hyperglycemia in early postnatal life of preterm infants with incompletely vascularized retinas is associated with increased risk of potentially blinding neovascular retinopathy of prematurity (ROP). Neovascular ROP (Phase II ROP) is a compensatory but ultimately pathological response to the suppres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Zhongjie, Lundgren, Pia, Pivodic, Aldina, Yagi, Hitomi, Harman, Jarrod C., Yang, Jay, Ko, Minji, Neilsen, Katherine, Talukdar, Saswata, Hellström, Ann, Smith, Lois E. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328855/ https://www.ncbi.nlm.nih.gov/pubmed/36943533 http://dx.doi.org/10.1007/s10456-023-09872-x

Ejemplares similares

Postnatal hyperglycemia alters amino acid profile in retinas (model of Phase I ROP)
por: Harman, Jarrod C., et al.
Publicado: (2023)

Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
por: Hellgren, Gunnel, et al.
Publicado: (2021)

Validation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) using retrospective clinical data
por: Pivodic, Aldina, et al.
Publicado: (2020)

Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial
por: Pivodic, Aldina, et al.
Publicado: (2022)

Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models
por: Tomita, Yohei, et al.
Publicado: (2020)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Retinal glial remodeling by FGF21 preserves retinal function during photoreceptor degeneration
por: Fu, Zhongjie, et al.
Publicado: (2021)

Association between low fatty acid levels and platelet count in infants with Retinopathy of Prematurity
por: Lundgren, Pia, et al.
Publicado: (2020)

Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity
por: Nilsson, Anders K., et al.
Publicado: (2021)

Correspondence to “Prediction of severe retinopathy of prematurity in 24–30 weeks gestation infants using birth characteristics”
por: Pivodic, Aldina, et al.
Publicado: (2021)

PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
por: Thompson, W. Clayton, et al.
Publicado: (2016)

Omega-3/Omega-6 Long-Chain Fatty Acid Imbalance in Phase I Retinopathy of Prematurity
por: Fu, Zhongjie, et al.
Publicado: (2022)

Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
por: Lund, Anna‐My, et al.
Publicado: (2019)

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021)

Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants: a follow-up of a randomized controlled trial
por: Lundgren, Pia, et al.
Publicado: (2023)

FGF21 and the Physiological Regulation of Macronutrient Preference
por: Hill, Cristal M, et al.
Publicado: (2020)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment – a review
por: Hård, Anna-Lena, et al.
Publicado: (2011)

In vivo noninvasive mitochondrial redox assessment of the optic nerve head to predict disease
por: Cakir, Bertan, et al.
Publicado: (2023)

Müller glial responses compensate for degenerating photoreceptors in retinitis pigmentosa
por: Tomita, Yohei, et al.
Publicado: (2021)

FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
por: Bernardo, Barbara, et al.
Publicado: (2015)

Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity: Development and Validation of the Revised DIGIROP Clinical Decision Support Tool
por: Pivodic, Aldina, et al.
Publicado: (2023)

Smartphone based ROP (S-ROP) screening—opportunities and challenges
por: patil, Jayaprakash, et al.
Publicado: (2020)

Screening for ROP
por: Quinn, Graham, et al.
Publicado: (2017)

Screening for ROP
por: Vinekar, Anand
Publicado: (2018)

Screening for ROP
por: Vinekar, Anand
Publicado: (2017)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice
por: Weng, Yan, et al.
Publicado: (2015)

Retrospective validation of G-ROP, CO-ROP, Alex-ROP, and ROPscore predictive algorithms in two Chinese medical centers
por: Lu, Yang, et al.
Publicado: (2023)

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
por: Inagaki, Takeshi
Publicado: (2015)

Metabolism in Retinopathy of Prematurity
por: Tomita, Yohei, et al.
Publicado: (2021)

Multi-modality biomarkers in the early prediction of ischaemic heart disease in middle-aged men during a 21-year follow-up
por: Sakalaki, Maria, et al.
Publicado: (2021)

Return On Process (ROP)
por: West, Michael
Publicado: (2016)

Immune Protection of Rhoptry Protein 21 (ROP21) of Toxoplasma gondii as a DNA Vaccine Against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2018)

Mother's Own Milk and Its Relationship to Growth and Morbidity in a Population-based Cohort of Extremely Preterm Infants
por: Lund, Anna-My, et al.
Publicado: (2022)

Correction to: Multi‑modality biomarkers in the early prediction of ischaemic heart disease in middle‑aged men during a 21‑year follow‑up
por: Sakalaki, Maria, et al.
Publicado: (2021)

FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis
por: Mottillo, Emilio P., et al.
Publicado: (2017)

FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology
por: Murata, Yusuke, et al.
Publicado: (2011)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j3irhioupqqh3o17hj3ktr8f3t